Turning the tide: From fibrosis to regeneration following anti-fibrogenic cell vaccination
- PMID: 36206727
- DOI: 10.1016/j.stem.2022.09.007
Turning the tide: From fibrosis to regeneration following anti-fibrogenic cell vaccination
Abstract
Fibrosis, the pathological end stage of chronic inflammatory diseases, results from extracellular matrix deposition by fibrogenic fibroblasts. In this issue of Cell Stem Cell, Sobecki et al. (2022) develop a novel vaccination-based immunotherapy against fibrogenic progenitor-restricted antigens, leading to the regression of fibrosis in concert with liver and lung regeneration.
Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
Vaccination-based immunotherapy to target profibrotic cells in liver and lung.Cell Stem Cell. 2022 Oct 6;29(10):1459-1474.e9. doi: 10.1016/j.stem.2022.08.012. Epub 2022 Sep 15. Cell Stem Cell. 2022. PMID: 36113462
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources